PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $32,416 | -67.7% | 14,668 | -62.9% | 0.00% | – |
| Q1 2023 | $100,376 | +217.9% | 39,518 | +134.0% | 0.00% | – |
| Q4 2022 | $31,575 | -12.3% | 16,885 | +20.4% | 0.00% | – |
| Q3 2022 | $36,000 | -83.6% | 14,020 | -68.8% | 0.00% | – |
| Q3 2021 | $219,000 | -64.4% | 44,892 | -50.3% | 0.00% | – |
| Q2 2021 | $616,000 | +422.0% | 90,318 | +442.3% | 0.00% | – |
| Q1 2021 | $118,000 | +11.3% | 16,655 | -1.5% | 0.00% | – |
| Q4 2020 | $106,000 | +41.3% | 16,910 | +22.5% | 0.00% | – |
| Q3 2020 | $75,000 | -56.4% | 13,800 | -58.2% | 0.00% | – |
| Q2 2020 | $172,000 | – | 33,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $40,639,000 | 22.88% |
| Abingworth LLP | 1,301,413 | $24,701,000 | 14.43% |
| Roumell Asset Management, LLC | 201,845 | $3,835,000 | 7.78% |
| GREAT POINT PARTNERS LLC | 453,878 | $8,624,000 | 3.41% |
| Aisling Capital LLC | 682,680 | $12,971,000 | 2.28% |
| Broadfin Capital, LLC | 530,283 | $10,075,000 | 0.56% |
| Tekla Capital Management LLC | 762,581 | $14,489,000 | 0.52% |
| Baupost Group | 1,544,498 | $29,345,000 | 0.49% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $5,264,000 | 0.47% |
| Lombard Odier Asset Management (USA) Corp | 135,710 | $2,578,000 | 0.22% |